The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Screening Regimens for Prostate Cancer

Scott Eggener, MD
Published Online: 9:59 PM, Fri May 22, 2015


Scott Eggener, MD, associate professor of surgery, co-director, Prostate Cancer Program, director, Transitional and Outcomes Research, Section of Urology, The University of Chicago Medicine, discusses screening for prostate cancer.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.